Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Articles by Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Latest Updated Articles
Perioperative Therapy: ASCO 2020 Data UpdatesAugust 13th 2020
Metastatic HR+ Breast Cancer UpdatesAugust 13th 2020
Metastatic Triple-Negative Breast Cancer Ongoing TrialsAugust 13th 2020
ASCO 2020 Data Updates: Metastatic HER2+ Breast CancerAugust 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
5